Literature DB >> 26031583

Change in glomerular volume and its clinicopathological impact after kidney transplantation.

Akimitsu Kobayashi1,2, Izumi Yamamoto1, Haruki Katsumata1, Takafumi Yamakawa1, Aki Mafune1, Yasuyuki Nakada1, Kentaro Koike1, Jun Mitome1, Jun Miki3, Hiroki Yamada3, Yudo Tanno1, Ichiro Ohkido1, Nobuo Tsuboi1, Keitaro Yokoyama1, Hiroyasu Yamamoto2, Takashi Yokoo1.   

Abstract

BACKGROUND: Both immunological and non-immunological etiologies affect graft function after kidney transplantation, including acute rejection, calcineurin inhibitor toxicity, and a recurrence of glomerulonephritis. Glomerular enlargement or glomerular sclerosis due to glomerular hyperfiltration related to increased renal blood flow is another cause. Although the glomerular volume in baseline biopsies predicts late allograft function, the relationship between allograft function and the annual changes in glomerular volume after kidney transplantation are unclear. AIM: We investigated changes in glomerular volume after kidney transplantation and their clinicopathological relationship.
METHODS: We enrolled 23 patients with stable kidney function without an episode of rejection or any complication resulting in a functional decrease in the graft. We measured glomerular volume (GV) using the Weibel-Gomez method and glomerular density (GD) using 0,1 h biopsy samples as baseline controls and 1 yr biopsy samples and investigated the association between the changes in them and clinical parameters, including graft function, proteinuria, and renal hemodynamic markers, including effective renal plasma flow (ERPF) and filtration fraction (FF). The ERPF was calculated from a 99mTc-mercaptoacetyltriglycine (MAG3) renogram.
RESULTS: The GV and ERPF increased significantly 1 yr after kidney transplantation. In contrast, proteinuria decreased significantly and Δproteinuria (1 yr - 1 month after transplantation) was correlated with ΔGV (P < 0.05, rs  = -0.467).
CONCLUSION: Glomerular enlargement 1 yr after transplantation may be related to improved proteinuria. It is possible that glomerular enlargement serves as a renal adaptation after kidney transplantation.
© 2015 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  Glomerular density; glomerular volume; kidney transplantation

Mesh:

Substances:

Year:  2015        PMID: 26031583     DOI: 10.1111/nep.12463

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  5 in total

1.  Proteinuric glomerulopathy in an adolescent with a distal partial trisomy chromosome 1.

Authors:  Takaya Sasaki; Masahiro Okabe; Takeshi Tosaki; Yu Honda; Masahiro Ishikawa; Nobuo Tsuboi; Takashi Yokoo
Journal:  CEN Case Rep       Date:  2018-05-16

2.  Correlation of Glomerular Size With Donor-Recipient Factors and With Response to Injury.

Authors:  Joseph P Grande; Erika S Helgeson; Arthur J Matas
Journal:  Transplantation       Date:  2021-11-01       Impact factor: 5.385

3.  Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia.

Authors:  Yufeng Yao; Yong Li; Xiaofei Zeng; Zheng Ye; Xia Li; Lu Zhang
Journal:  Front Pharmacol       Date:  2018-10-29       Impact factor: 5.810

4.  Differential effects of sodium chloride and monosodium glutamate on kidney of adult and aging mice.

Authors:  Michele Celestino; Valeria Balmaceda Valdez; Paola Brun; Ignazio Castagliuolo; Carla Mucignat-Caretta
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

5.  Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation.

Authors:  Mayuko Kawabe; Izumi Yamamoto; Takafumi Yamakawa; Haruki Katsumata; Nao Isaka; Ai Katsuma; Yasuyuki Nakada; Akimitsu Kobayashi; Kentaro Koike; Hiroyuki Ueda; Yudo Tanno; Yusuke Koike; Jun Miki; Hiroki Yamada; Takahiro Kimura; Ichiro Ohkido; Nobuo Tsuboi; Hiroyasu Yamamoto; Hiromi Kojima; Takashi Yokoo
Journal:  Front Immunol       Date:  2020-09-03       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.